Trial intelligence / Profile preview

Lidocaine/Dexamethasone for IANB in Irreversible Pulpitis

NCT03531970Phase 3Completed

Start
Aug 2016
Primary completion
Aug 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of dexamethasone in irreversible pulpitis. Started Aug 2016; status: completed.

02

Drugs

dexamethasone
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on NCT03531970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03531970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call